$19.74
0.090.46%
At close: -
$19.74
0.000.00%
After Hours: Feb 14, 4:00 PM EDT
Comments
Loading...
Kiniksa Pharmaceuticals (KNSA) Forecast
NewsEarningsKiniksa Pharmaceuticals (KNSA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestKiniksa Pharmaceuticals (NASDAQ:KNSA) Stock Quotes, Forecast and News Summary
Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kiniksa Pharmaceuticals (KNSA) stock?
You can purchase shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA) through any online brokerage.
Who are Kiniksa Pharmaceuticals (KNSA) competitors?
Other companies in Kiniksa Pharmaceuticals’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Syndax Pharmaceuticals (NASDAQ:SNDX), Arcutis Biotherapeutics (NASDAQ:ARQT) and CareDx (NASDAQ:CDNA).
What is the forecast, or price target, for Kiniksa Pharmaceuticals (KNSA) stock?
Kiniksa Pharmaceuticals has a consensus price target of $35.83.
What is the current price for Kiniksa Pharmaceuticals (KNSA)?
The stock price for Kiniksa Pharmaceuticals (NASDAQ: KNSA) is $19.74 last updated February 14, 2025 at 4:00 PM EST.
Does Kiniksa Pharmaceuticals (KNSA) pay a dividend?
There are no upcoming dividends for Kiniksa Pharmaceuticals.
When is Kiniksa Pharmaceuticals (NASDAQ:KNSA) reporting earnings?
Kiniksa Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, April 22, 2025.
Is Kiniksa Pharmaceuticals (KNSA) going to split?
There is no upcoming split for Kiniksa Pharmaceuticals.
What sector and industry does Kiniksa Pharmaceuticals (KNSA) operate in?
Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.